povorcitinib
Showing 1 - 6 of 6
NonSegmental Vitiligo Trial (Povorcitinib, Placebo)
Not yet recruiting
- NonSegmental Vitiligo
- Povorcitinib
- Placebo
- (no location specified)
Oct 27, 2023
NonSegmental Vitiligo Trial (Povorcitinib, Placebo)
Not yet recruiting
- NonSegmental Vitiligo
- Povorcitinib
- Placebo
- (no location specified)
Oct 27, 2023
Urticaria, Chronic Spontaneous Urticaria, Chronic Idiopathic Urticaria Trial (Povorcitinib, Placebo)
Not yet recruiting
- Urticaria
- +5 more
- Povorcitinib
- Placebo
- (no location specified)
Jul 6, 2023
Moderate to Severe Asthma Trial (povorcitinib, , ICS-LABA)
Not yet recruiting
- Moderate to Severe Asthma
- povorcitinib
- +2 more
- (no location specified)
May 9, 2023
Hidradenitis Suppurativa (HS) Trial (Povorcitinib, Placebo)
Not yet recruiting
- Hidradenitis Suppurativa (HS)
- Povorcitinib
- Placebo
- (no location specified)
Nov 10, 2022
Hidradenitis Suppurativa (HS) Trial in Worldwide (Povorcitinib, Placebo)
Recruiting
- Hidradenitis Suppurativa (HS)
- Povorcitinib
- Placebo
-
Phoenix, Arizona
- +44 more
Jan 12, 2023